Ahmad Reza Dehpour | Pharmaceutical Science | Best Researcher Award

Published on by Environmental Scientists

Best Researcher Award

Ahmad Reza Dehpour
Affiliation Tehran University of Medical Science
Country Iran
Scopus ID 7005678616
Documents 934
Citations 20,529
h-index 59
Subject Area Pharmaceutical Science
Event International Environmental Scientists Award
ORCID 0000-0002-8001-5565

Ahmad Reza Dehpour
Tehran University of Medical Sciences

Ahmad Reza Dehpour is affiliated with Tehran University of Medical Science in Iran and has a documented research profile in Pharmaceutical Science. The supplied Scopus record reports 934 documents, 20,529 citations, and an h-index of 59, providing substantial bibliometric evidence of scholarly activity and research influence. [1]

Abstract

Ahmad Reza Dehpour’s academic profile reflects extensive scholarly activity in Pharmaceutical Science, with an institutional affiliation at Tehran University of Medical Science. The supplied bibliometric record identifies 934 documents, 20,529 citations, and an h-index of 59, indicating a substantial publication and citation record. [1]

Keywords

Ahmad Reza Dehpour; Tehran University of Medical Science; Iran; Pharmaceutical Science; pharmacological research; drug research; biomedical science; publications; citations; h-index; research recognition.

Introduction

Pharmaceutical Science integrates drug discovery, pharmacology, formulation, therapeutic development, and related biomedical disciplines. Research within this field contributes to understanding medicines and their biological effects while supporting evidence-based approaches to pharmaceutical and healthcare innovation. [2]

Research Profile

The supplied profile identifies Ahmad Reza Dehpour with Tehran University of Medical Science and lists Pharmaceutical Science as the principal subject area. The Scopus author identifier is 7005678616, with 934 documents, 20,529 citations, and an h-index of 59 reported in the provided record. [1]

Research Contributions

A research profile of this scale indicates sustained scholarly engagement with pharmaceutical and pharmacological questions across a substantial body of scientific literature. Specific contributions should be assessed from individual publications, research findings, collaborations, and documented applications rather than from bibliometric indicators alone. [3]

Publications

The supplied Scopus information records 934 documents associated with the researcher. The available input does not specify individual article titles, journals, publication years, or article-level DOI identifiers; therefore, specific publications are not attributed in this profile. [1]

Research Impact

The supplied bibliometric record reports 20,529 citations and an h-index of 59. These measures indicate considerable citation activity within the indexed scholarly record, although citation metrics should be interpreted together with research quality, field-specific practices, collaboration, and substantive scientific contributions. [4]

Award Suitability

The documented publication volume, citation record, and h-index provide relevant quantitative evidence for consideration under a Best Researcher Award framework. Final eligibility and award selection should be determined through the official International Environmental Scientists Award nomination and evaluation procedures. [5]

Conclusion

Ahmad Reza Dehpour’s supplied academic record documents extensive research activity in Pharmaceutical Science, affiliation with Tehran University of Medical Science, and strong bibliometric indicators comprising 934 documents, 20,529 citations, and an h-index of 59. These indicators provide a quantitative foundation for academic recognition.

References

  1. Elsevier. (n.d.). Scopus author details: Ahmad Reza Dehpour, Author ID 7005678616. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7005678616
  2. National Center for Biotechnology Information. (n.d.). PubMed and biomedical literature resources. National Library of Medicine.
    https://pubmed.ncbi.nlm.nih.gov/
  3. World Health Organization. (n.d.). Medicines and pharmaceutical research resources. World Health Organization.
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  5. International Environmental Scientists Award. (n.d.). Official Award Website.
    https://environmentalscientists.org/
  6. Crossref. (n.d.). DOI and scholarly metadata services. Crossref.

Alexandra Gaspar | Medicinal chemistry | Women Researcher Award

Published on by Environmental Scientists

Women Researcher Award

Alexandra Gaspar
Faculty of Sciences, University of Porto
Alexandra Gaspar
Affiliation Faculty of Sciences, University of Porto
Country Portugal
Scopus ID 7102545856
Documents 56
Citations 3157
h-index 25
Subject Area Medicinal chemistry
Event Environmental Scientists Award
ORCID
0000-0002-3892-4124

Alexandra Gaspar distinguished scholarly contributions and sustained academic achievements in scientific research and innovation. Alexandra Gaspar, affiliated with the Faculty of Sciences at the University of Porto, Portugal, has contributed to the advancement of medicinal chemistry through interdisciplinary research, publication activity, and scientific collaboration. Her academic profile reflects a sustained commitment to pharmaceutical sciences, molecular design, and medicinal chemistry applications relevant to environmental and biomedical challenges.[1]

Abstract

Alexandra Gaspar has established a recognized academic profile in medicinal chemistry, with scholarly activities emphasizing pharmaceutical innovation, bioactive molecular development, and interdisciplinary scientific applications. Her publication record, citation performance, and international research visibility demonstrate active engagement in medicinal and pharmaceutical sciences. Through contributions to peer-reviewed literature and collaborative scientific research, her work has supported ongoing developments in molecular therapeutics and chemical biology.[1][2]

Keywords

Women Researcher Award, Medicinal Chemistry, Pharmaceutical Sciences, Drug Discovery, Portugal, University of Porto, Molecular Design, Chemical Biology, Environmental Scientists Award, Scientific Research

Introduction

Medicinal chemistry remains an important interdisciplinary scientific field integrating chemistry, biology, and pharmaceutical sciences to support therapeutic development and molecular innovation. Researchers working in this area contribute to the design, synthesis, and evaluation of compounds with biological relevance. Alexandra Gaspar’s academic activities align with these objectives through investigations related to pharmaceutical compounds and medicinal chemistry methodologies. Her research profile reflects a combination of scientific productivity and international academic engagement within biomedical and pharmaceutical research domains.[1]

Research Profile

Alexandra Gaspar is associated with the Faculty of Sciences at the University of Porto in Portugal, where she has contributed to medicinal chemistry research and related pharmaceutical sciences. Her Scopus author profile documents 56 indexed publications with a citation count exceeding 3,100 and an h-index of 25, indicating notable scholarly visibility within the scientific community.[1]

Her academic work includes collaboration across interdisciplinary research environments and contributions to studies involving biologically active compounds, medicinal chemistry strategies, and molecular therapeutic investigations. These activities have contributed to the dissemination of scientific findings in peer-reviewed journals and international academic platforms.[2]

Research Contributions

The research contributions associated with Alexandra Gaspar encompass medicinal chemistry applications and pharmaceutical compound investigations. Her work has included the evaluation of molecular structures, chemical synthesis approaches, and studies associated with therapeutic and biological activities. Such investigations contribute to broader scientific understanding in medicinal and pharmaceutical chemistry.

  • Research involving medicinal chemistry and pharmaceutical sciences.
  • Contributions to peer-reviewed scientific publications and collaborative studies.
  • Participation in interdisciplinary molecular and therapeutic research initiatives.
  • Scientific dissemination through academic journals and international research platforms.

Publications

Alexandra Gaspar has contributed to scientific literature indexed in major academic databases. Selected publication themes include medicinal chemistry, molecular therapeutics, and pharmaceutical research methodologies. Her publication activity has contributed to citation visibility and scholarly engagement within the biomedical sciences community.[2]

  • Studies related to medicinal and pharmaceutical chemistry.
  • Research on biologically active molecules and therapeutic applications.

Research Impact

The citation performance and h-index associated with Alexandra Gaspar’s academic record indicate measurable scholarly influence within medicinal chemistry and pharmaceutical research. Citation metrics frequently reflect research visibility, scientific utilization, and interdisciplinary engagement. Her publication profile demonstrates continued participation in international scientific communication and collaborative knowledge production.[1]

Research impact in medicinal chemistry also extends to the development of methodologies and scientific approaches supporting biomedical and pharmaceutical innovation. Contributions within these areas are important for advancing scientific understanding and supporting future therapeutic investigations.

Award Suitability

Alexandra Gaspar’s scholarly profile aligns with the objectives of the Women Researcher Award due to her sustained research activity, publication performance, and scientific contributions within medicinal chemistry. Her academic engagement demonstrates participation in internationally relevant scientific research and interdisciplinary collaboration. The combination of publication productivity, citation impact, and institutional affiliation supports recognition within the Environmental Scientists Award framework.[1][2]

Conclusion

The Women Researcher Award article for Alexandra Gaspar presents a structured overview of her academic profile, research achievements, and scholarly visibility within medicinal chemistry. Her scientific activities demonstrate continued participation in pharmaceutical and biomedical research, with measurable citation impact and publication engagement. The profile reflects a contribution to scientific advancement consistent with international academic recognition standards.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Alexandra Gaspar, Author ID 7102545856. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7102545856
  2. ORCID. (n.d.). Alexandra Gaspar ORCID profile.
    https://orcid.org/0000-0002-3892-4124
  3. Gaspar, A., & Garrido, J. M. P. J. (2026). Unveiling RNA ligands: Harnessing NMR for hit generation.European Journal of Medicinal Chemistry.  https://www.sciencedirect.com/science/article/abs/pii/S0223523425012607?via%3Dihub
  4. Gaspar, A., Garrido, E. M. P. J., Borges, F., & Garrido, J. M. P. J. (2024). Biological and medicinal properties of natural chromones and chromanones. https://pubs.acs.org/doi/10.1021/acsomega.4c00771
  5. Silva, V. F. M., Silva, A., Garrido, E. M. P. J., Borges, F., Gaspar, A., & Garrido, J. M. P. J. (2024). Microencapsulation of the biocide benzisothiazolinone (BIT) by inclusion in methyl-β-cyclodextrin and screening of its antibacterial and ecotoxicity properties. https://www.mdpi.com/2305-6304/12/9/674

Haya Alzeer | Pharmacology | Research Excellence Award

Published on by Environmental Scientists

Research Excellence Award

Haya Alzeer
Saudi Food and Drug Authority

 

Haya Alzeer
Researcher Haya Alzeer
Affiliation Saudi Food and Drug Authority
Country Saudi Arabia
Scopus ID 57202029321
Citations 44 by 4 docments
h-index 3
Subject Area Pharmacology
Event International Environmental Scientists Award
ORCID
0009-0001-2301-4793

Haya Alzeer recognizes scholarly achievement, scientific contribution, and professional dedication within the fields of pharmacology and public health research. Haya Alzeer, affiliated with the Saudi Food and Drug Authority, has contributed to scientific investigations associated with pharmacological sciences, healthcare evaluation, and evidence-based analytical approaches. Her academic profile reflects continued engagement with peer-reviewed scientific literature and international research indexing platforms.[1]

Abstract

This academic recognition article documents the scholarly profile and research-oriented achievements of Haya Alzeer in the domain of pharmacology and health sciences. Her contributions are associated with scientific evaluation methodologies, healthcare-related analytical studies, and participation in indexed academic publishing platforms. The recognition under the International Environmental Scientists Award framework reflects the importance of interdisciplinary scientific advancement, regulatory awareness, and evidence-driven healthcare research. Indexed citation metrics and author profiling databases indicate sustained academic engagement and measurable research visibility within the broader scientific community.[1][2]

Keywords

Research Excellence Award, Pharmacology, Saudi Food and Drug Authority, Scientific Recognition, Academic Research, Healthcare Sciences, Scopus Indexed Research, Evidence-Based Medicine, Scientific Publications, International Environmental Scientists Award

Introduction

The advancement of pharmacological and healthcare sciences relies on systematic investigation, scientific transparency, and evidence-based methodologies. Academic recognition programs such as the Research Excellence Award are designed to acknowledge researchers who demonstrate scholarly productivity, scientific integrity, and measurable contributions to their disciplines. Haya Alzeer’s academic profile reflects participation in internationally indexed research activities and alignment with contemporary healthcare research standards.[1]

The Saudi Food and Drug Authority plays an important role in supporting scientific evaluation, healthcare safety, and regulatory research initiatives in Saudi Arabia. Researchers affiliated with such institutions contribute to the development of pharmacological assessments, public health monitoring, and analytical investigations relevant to healthcare systems and scientific governance.[3]

Research Profile

Haya Alzeer maintains a recognized academic presence through indexed scholarly databases and professional research identifiers. Her Scopus author profile documents research publications, citation records, and subject-area classification associated with pharmacology and healthcare sciences. The availability of an ORCID identifier further supports research transparency and author identity verification across international publishing systems.[1][4]

Research Contributions

The research contributions associated with Haya Alzeer involve participation in scientific studies relevant to healthcare assessment, pharmacological investigation, and evidence-based analytical practices. Such contributions support broader scientific objectives related to medication evaluation, healthcare quality assurance, and scientific data interpretation. The integration of indexed research findings into academic literature contributes to the advancement of reproducible scientific methodologies and interdisciplinary collaboration.[1]

Contemporary pharmacological research requires rigorous analytical standards, peer-review validation, and adherence to international publication ethics. Researchers operating within regulatory and healthcare institutions frequently contribute to the evaluation of safety frameworks, healthcare monitoring systems, and scientific reporting standards. These activities strengthen scientific reliability and public trust within healthcare-oriented research environments.[3]

Publications

Selected scholarly publications and indexed research records associated with Haya Alzeer demonstrate engagement with scientific publishing standards and peer-reviewed dissemination channels.[1]

Research Impact

Research impact may be evaluated through indexed citations, scholarly visibility, publication quality, and engagement with evidence-based scientific practices. Citation metrics associated with Haya Alzeer’s academic profile demonstrate that her published work has contributed to ongoing scholarly discussions within healthcare and pharmacological sciences.[1]

The broader significance of scientific contributions in pharmacology extends beyond publication metrics to include support for healthcare evaluation, regulatory science, and public health awareness. Research dissemination through internationally indexed databases facilitates collaboration, reproducibility, and long-term scientific accessibility.[2]

Award Suitability

Haya Alzeer’s scholarly profile demonstrates alignment with the objectives commonly associated with the Research Excellence Award. Her indexed publication record, citation performance, institutional affiliation, and scientific engagement collectively support recognition within an international academic award framework. Participation in peer-reviewed scientific activities and the maintenance of professional research identifiers further indicate commitment to research integrity and scholarly visibility.[1][4]

The International Environmental Scientists Award promotes interdisciplinary scientific recognition and encourages continued advancement in research quality, analytical rigor, and academic collaboration. Contributions connected to healthcare sciences and pharmacology remain essential to the development of evidence-based scientific systems and public health-oriented innovation.[6]

Conclusion

The Research Excellence Award article on Haya Alzeer presents a structured overview of her academic profile, institutional affiliation, indexed publication record, and measurable scholarly visibility within pharmacology and healthcare sciences. Through participation in peer-reviewed scientific activities and internationally recognized indexing systems, her work contributes to ongoing academic and healthcare-related research discussions. The documented research metrics and professional affiliations support recognition within a global scientific and academic context.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Haya Alzeer, Author ID 57202029321. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57202029321
  2. ORCID. (n.d.). ORCID record for Haya Alzeer.https://orcid.org/0009-0001-2301-4793
  3. Saudi Food and Drug Authority. (n.d.). Scientific and regulatory activities in healthcare and pharmacology.https://www.sfda.gov.sa/en
  4. Haak, L. L., Fenner, M., Paglione, L., Pentz, E., & Ratner, H. (2012). ORCID: a system to uniquely identify researchers. Learned Publishing, 25(4), 259–264.https://doi.org/10.1087/20120404
  5. Alzeer, H., et al. (2023). Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray. Saudi Pharmaceutical Journal. https://pubmed.ncbi.nlm.nih.gov/37791036/

Joaquín María Campos Rosa | Pharmacology | Outstanding Scientist Award

Published on by Environmental Scientists

Prof. Joaquín María Campos Rosa | Pharmacology | Outstanding Scientist Award

Professor Emeritus of the University of Granada | The University of Granada University | Spain

Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry  has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design.

                            Citation Metrics ( Scopus )

4500

3750

3000

2250

1500

750

0

 

Citations
3894
h-index
34
i10-index
92

Citations

Documents

h-index

 

View Google Scholar Profile View ORCID Profile